Claire Gelfman

Company: Foundation Fighting Blindness

Job title: Chief Scientific Officer

Seminars:

Panel Discussion: Maximizing Ophthalmic Gene Therapy Trial Success Strategies 9:30 am

Discussing strategies for improving trial design to mitigate risks and enhance success Exploring the regulatory landscape and its impact on gene therapy trials, including approval processes and compliance requirements Detailing actionable steps derived from past failures to inform future gene therapy endeavours and maximize trial outcomesRead more

day: Day Two 12th

Chair’s Closing Remarks 5:00 pm

Read more

day: Day One 11th

Chair’s Opening Remarks 8:50 am

Read more

day: Day One 11th

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.